181 related articles for article (PubMed ID: 26548633)
1. Adenine nucleotide translocase 1 overexpression protects cardiomyocytes against hypoxia via increased ERK1/2 and AKT activation.
Winter J; Klumpe I; Heger J; Rauch U; Schultheiss HP; Landmesser U; Dörner A
Cell Signal; 2016 Jan; 28(1):152-9. PubMed ID: 26548633
[TBL] [Abstract][Full Text] [Related]
2. Transgenic overexpression of adenine nucleotide translocase 1 protects ischemic hearts against oxidative stress.
Klumpe I; Savvatis K; Westermann D; Tschöpe C; Rauch U; Landmesser U; Schultheiss HP; Dörner A
J Mol Med (Berl); 2016 Jun; 94(6):645-53. PubMed ID: 27080394
[TBL] [Abstract][Full Text] [Related]
3. Adenine Nucleotide Translocase 1 Expression is Coupled to the HSP27-Mediated TLR4 Signaling in Cardiomyocytes.
Winter J; Hammer E; Heger J; Schultheiss HP; Rauch U; Landmesser U; Dörner A
Cells; 2019 Dec; 8(12):. PubMed ID: 31817787
[TBL] [Abstract][Full Text] [Related]
4. Transgenic overexpression of the adenine nucleotide translocase 1 protects cardiomyocytes against TGFβ1-induced apoptosis by stabilization of the mitochondrial permeability transition pore.
Heger J; Abdallah Y; Shahzad T; Klumpe I; Piper HM; Schultheiss HP; Schlüter KD; Schulz R; Euler G; Dörner A
J Mol Cell Cardiol; 2012 Jul; 53(1):73-81. PubMed ID: 22564366
[TBL] [Abstract][Full Text] [Related]
5. Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease.
Walther T; Tschöpe C; Sterner-Kock A; Westermann D; Heringer-Walther S; Riad A; Nikolic A; Wang Y; Ebermann L; Siems WE; Bader M; Shakibaei M; Schultheiss HP; Dörner A
Circulation; 2007 Jan; 115(3):333-44. PubMed ID: 17210842
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
Xu R; Chen J; Cong X; Hu S; Chen X
J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
[TBL] [Abstract][Full Text] [Related]
7. Transgenic overexpression of heart-specific adenine nucleotide translocase 1 positively affects contractile function in cardiomyocytes.
Vogelpohl I; Vetter R; Heger J; Ebermann L; Euler G; Schultheiss HP; Dörner A
Cell Physiol Biochem; 2011; 27(2):121-8. PubMed ID: 21325829
[TBL] [Abstract][Full Text] [Related]
8. Adenine Nucleotide Translocase 1 Expression Modulates the Immune Response in Ischemic Hearts.
Yergöz F; Friebel J; Kränkel N; Rauch-Kroehnert U; Schultheiss HP; Landmesser U; Dörner A
Cells; 2021 Aug; 10(8):. PubMed ID: 34440901
[TBL] [Abstract][Full Text] [Related]
9. Adenine nucleotide translocase-1 induces cardiomyocyte death through upregulation of the pro-apoptotic protein Bax.
Baines CP; Molkentin JD
J Mol Cell Cardiol; 2009 Jun; 46(6):969-77. PubMed ID: 19452617
[TBL] [Abstract][Full Text] [Related]
10. Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2.
Cho DH; Lee HJ; Kim HJ; Hong SH; Pyo JO; Cho C; Jung YK
Oncogene; 2007 Apr; 26(19):2809-14. PubMed ID: 17086211
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression.
Morisco C; Marrone C; Trimarco V; Crispo S; Monti MG; Sadoshima J; Trimarco B
Cardiovasc Res; 2007 Dec; 76(3):453-64. PubMed ID: 17698050
[TBL] [Abstract][Full Text] [Related]
12. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.
Davidson SM; Hausenloy D; Duchen MR; Yellon DM
Int J Biochem Cell Biol; 2006 Mar; 38(3):414-9. PubMed ID: 16280253
[TBL] [Abstract][Full Text] [Related]
13. The cytoprotective effect of biglycan core protein involves Toll-like receptor 4 signaling in cardiomyocytes.
Gáspár R; Pipicz M; Hawchar F; Kovács D; Djirackor L; Görbe A; Varga ZV; Kiricsi M; Petrovski G; Gácser A; Csonka C; Csont T
J Mol Cell Cardiol; 2016 Oct; 99():138-150. PubMed ID: 27515282
[TBL] [Abstract][Full Text] [Related]
14. C3G overexpression promotes the survival of rat-derived H9C2 cardiomyocytes by p-ERK1/2.
Zhang X; Li G; Zhang L; Yang D; Zhang Z; Yan A; Linghu H
Cell Biol Int; 2013 Oct; 37(10):1106-13. PubMed ID: 23686869
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin enhances mitochondrial biogenesis in cardiomyocytes exposed to chronic hypoxia through Akt/eNOS signalling pathway.
Qin C; Zhou S; Xiao Y; Chen L
Cell Biol Int; 2014 Mar; 38(3):335-42. PubMed ID: 24436050
[TBL] [Abstract][Full Text] [Related]
16. Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes.
Markou T; Makridou Z; Galatou E; Lazou A
Eur J Pharmacol; 2011 Sep; 667(1-3):298-305. PubMed ID: 21664904
[TBL] [Abstract][Full Text] [Related]
17. Exogenous spermine inhibits hypoxia/ischemia-induced myocardial apoptosis via regulation of mitochondrial permeability transition pore and associated pathways.
Wei C; Li H; Wang Y; Peng X; Shao H; Li H; Bai S; Xu C
Exp Biol Med (Maywood); 2016 Aug; 241(14):1505-15. PubMed ID: 27190250
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide pretreatment protects cardiomyocytes against hypoxia-induced cell death by improving mitochondrial stress.
Tong DL; Zhang DX; Xiang F; Teng M; Jiang XP; Hou JM; Zhang Q; Huang YS
Pharmacology; 2012; 90(1-2):11-8. PubMed ID: 22699421
[TBL] [Abstract][Full Text] [Related]
19. The phosphatidylinositol 3-kinase-Akt pathway protects cardiomyocytes from ischaemic and hypoxic apoptosis via mitochondrial function.
Song HP; Zhang L; Dang YM; Yan H; Chu ZG; Huang YS
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):598-604. PubMed ID: 20082630
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation.
Yin Y; Guan Y; Duan J; Wei G; Zhu Y; Quan W; Guo C; Zhou D; Wang Y; Xi M; Wen A
Eur J Pharmacol; 2013 Jan; 699(1-3):219-26. PubMed ID: 23200898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
